Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02914405
Title Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma (MiniVan)
Acronym MiniVan
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Hospital Southampton NHS Foundation Trust
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | GBR


No variant requirements are available.